Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Form 4 Petros Pharmaceuticals, For: Apr 07 Filed by: Bernstein Bruce
-
Agrify Announces its First Total Turn-Key Agreement in New Jersey with Loud Wellness
-
Agrify Announces its First Total Turn-Key Agreement in New Jersey with Loud Wellness
-
SQZ Biotechnologies (SQZ) Reports New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo
-
SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo
-
SCWorx Corp. (WORX) Announces Preliminary Court Approval of Shareholder Derivative Settlement
-
SCWorx Announces Preliminary Court Approval of Shareholder Derivative Settlement
-
Bernstein Reiterates Outperform Rating on Taiwan Semiconductor Manufacturing Co. Ltd. (2330:TT) (TSM)
-
Innovative Therapy that "Tricks" and Destroys Cancer Cells Advances to Clinical Trial
-
U.S. schools pull more than 1,000 book titles in 'unparalleled' censorship bid, report finds
-
The Hartford Announces Goal Of Net Zero Greenhouse Gas Emissions For All Operations By 2050
-
LogicSource Secures $180 Million Growth Investment from FTV Capital to Drive Efficiency and Profitability for the World's Leading Brands
-
Scientists Discover Gene Mutation That Signals Aggressive Melanoma
-
Kentucky Governor Beshear vetoes transgender sports ban
-
Form 4 Synaptogenix, Inc. For: Apr 05 Filed by: Bernstein Bruce
-
Introducing Dwellwell™, the First-of-Its-Kind ‘Check Engine Light’ for Residential Properties
-
CORRECTING and REPLACING PHOTO Introducing Dwellwell™, the First-of-Its-Kind ‘Check Engine Light’ for Residential Properties
-
European equity funds had outflows for first time in two years in March
-
Tegmine Therapeutics Announces Collaboration with Alloy Therapeutics to Advance Solid Tumor Treatment
-
Metrc Announces New Track-And-Trace Contract with the State of Mississippi
-
Metrc Announces New Track-And-Trace Contract with the State of Mississippi
-
Luxury retailer Farfetch invests in Neiman Marcus
-
SQZ Biotechnologies (SQZ) Publishes Preclinical Research on SQZ TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
-
SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
-
ETA Names Forty Under 40: Pacesetters of the Payments Technology Industry
-
Imprint partners with WeWoreWhat to launch the WeWoreWhat Rewards VisaⓇ Card
-
AlphaSense Adds CFRA as Latest Contributor to Wall Street Insights®
-
Form 4/A VECTOR GROUP LTD For: Mar 31 Filed by: BERNSTEIN RONALD J
-
Sacramento police say there were 'multiple' shooters in violence that left six dead
-
Form 4 VECTOR GROUP LTD For: Mar 31 Filed by: BERNSTEIN RONALD J
-
JOHN WILLIAMS & YO-YO MA REUNITE ON UPCOMING ALBUM, A GATHERING OF FRIENDS, WITH THE NEW YORK PHILHARMONIC - AVAILABLE MAY 20, 2022
-
At California gas station, Republicans woo voters angry over fuel prices - but it's complicated
-
In setback for Democrats, New York judge throws out new congressional map
-
Form 4 ACCO BRANDS Corp For: Mar 29 Filed by: Bernstein Roxanne M
-
Disney Original Documentary Announces New Feature Project on Beloved Muppets Creator and Visionary Jim Henson, Directed by Ron Howard and Produced by Brian Grazer and Imagine Documentaries
-
Commercial Real Estate General Partners Raised More Capital in 2021 Using Juniper Square Digital Subscriptions
-
SBA Communications (SBAC) Announces Election of Jay L. Johnson to Board of Directors
-
SBA Communications Announces Election of Jay L. Johnson to Board of Directors
-
Lieff Cabraser and Sauder Schelkopf Announce Broad Denial of Defendants' Motions to Dismiss in Physical, Sexual, and Emotional Abuse Lawsuits Against Devereux Behavioral Health
-
Takeda Pharmaceutical (TAK) Announces Approval of TAKHZYRO in Japan for Prophylaxis Against Acute Attacks of Hereditary Angioedema
-
Takeda’s TAKHZYRO® (lanadelumab) Approved in Japan for Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
-
Debevoise Adds John (Jay) Neukom as Intellectual Property Litigation Partner in San Francisco
-
Risk-Reward for Tesla (TSLA) Shares 'Not Attractive' at Current Levels - Bernstein's Sacconaghi
-
BlackRock Again Tops Broadridge's Fund Brand 50 Global Asset Manager Rankings
-
U.S. FDA approves UCB's drug for rare childhood epilepsy
-
Arizona, Oklahoma legislatures pass transgender sports bans
-
Lieff Cabraser & Co-Counsel Announce That Students Reach Agreement With University of Michigan to Implement Landmark Reforms Addressing On-Campus Sexual Misconduct
-
FTV Capital Raises Record Growth Equity Fund at $2.3 Billion
-
Nvidia CEO says interested in exploring chip manufacturing with Intel
-
BIOGEN INC. (NASDAQ: BIIB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen

